Skip to main content
. Author manuscript; available in PMC: 2016 Oct 1.
Published in final edited form as: Mol Cancer Ther. 2015 Jul 23;14(10):2343–2352. doi: 10.1158/1535-7163.MCT-14-1051

Figure 6. Silencing Egr1 suppresses tumor growth in a glioma and colorectal mouse tumor model.

Figure 6

(A) Mean volumes of GL261 and HCT116 tumors bearing either scrambled or Egr1-targeting shRNA at various time points following implantation (B) Average number of days it took for tumors to reach 0.25cm3 (GL261) and 1.0cm3 (HCT116); *p<0.05.